Hair thinning that creeps up over years, at the temples, the crown or along the part, is usually androgenetic alopecia. The AAD describes it as the most common cause of hair loss in both men and women. This article explains what happens inside the follicle and what the evidence says about treatment.
How common it is
DermNet describes male pattern hair loss as affecting nearly all men at some point. It reports that up to half of white men show some hair loss by age 50, and possibly 80% by age 70, while Japanese and Chinese men are far less affected. The AAD notes that it can start in the late teens or early twenties.
For women, DermNet reports that about 40% show signs of hair loss by age 50, and that fewer than 45% reach age 80 with a full head of hair. The AAD notes that female pattern hair loss usually begins in midlife, in the 40s to 60s, though it can start earlier, and is more common after menopause.
How it works
The normal hair cycle
Each scalp hair grows from a follicle that cycles through phases. The growth phase, anagen, lasts years. DermNet gives it as roughly 2 to 6 years for scalp hair.
What changes in androgenetic alopecia
DermNet explains that in men, scalp follicles are genetically more sensitive to dihydrotestosterone (DHT), a hormone made under the control of the enzyme 5-alpha reductase. DHT is believed to shorten the growth phase from years to weeks or months.
With each cycle, the follicles shrink, a process called miniaturization. DermNet notes that scalp hairs normally grow in small tufts of three to four. As follicles miniaturize, they produce finer and shorter hairs, until bare scalp shows between them.
The role of genes
The condition is inherited. DermNet describes several genes involved, passed down from either or both parents. It also notes that genetic tests to predict balding are currently unreliable and are not recommended.
Why women are different
In women, the hormone picture is less clear. DermNet notes that most women with female pattern hair loss have normal blood androgen levels, and that the role of estrogen is also uncertain. Some women do have high androgen levels, often with acne, irregular periods and extra facial or body hair, as can happen with polycystic ovary syndrome. Most women with polycystic ovary syndrome, however, do not have hair loss.
How the pattern differs
| Feature | Men | Women |
|---|---|---|
| Early sign | Receding hairline at the front and temples | Widening part (AAD) |
| Later pattern | Thinning on the top and front of the head | Diffuse thinning over the top; temples may recede |
| Complete baldness | Can occur | Uncommon; women usually do not lose all their hair (AAD) |
| Hormone link | Follicle sensitivity to DHT | Unclear; most have normal androgen levels |
| Course | Progressive | DermNet notes bursts of loss lasting 3 to 6 months, then stable periods of 6 to 18 months |
What the evidence shows for treatment
The goal of treatment is usually to slow or stop further loss. DermNet notes that regrowth is possible but results vary.
Topical minoxidil
The AAD lists topical minoxidil as FDA-approved and available without a prescription, for both men and women. For women, the AAD calls it the most-recommended treatment and notes it comes in 2% and 5% strengths.
A 2017 summary of a Cochrane review, published in JAMA Dermatology, found low- to moderate-quality evidence that topical minoxidil at 2% and 5% improved female pattern hair loss. DermNet adds that the stronger 5% version is more likely to irritate and to cause unwanted hair growth elsewhere.
Finasteride (men)
Finasteride is a prescription pill that blocks the enzyme that makes DHT. The AAD lists it as FDA-approved for men and states that it has been shown to slow further hair loss in about 80% to 90% of men taking it, with some men regrowing hair.
For women, the same 2017 summary found low-quality evidence that finasteride was no more effective than placebo. The AAD notes that pills such as spironolactone and finasteride are sometimes prescribed off-label for women.
Other options
| Treatment | What the sources say |
|---|---|
| Low-dose oral minoxidil | Used off-label, alone or with other medicines; may cause unwanted body hair (DermNet) |
| Spironolactone and other anti-androgens | Off-label for women; can cause birth defects (AAD) |
| Hair transplant | Permanent option for men; for women, requires enough healthy donor hair (AAD) |
| Platelet-rich plasma (PRP) | Under investigation (DermNet); not permanent, needs maintenance injections (AAD) |
| Low-level laser devices | Unproven benefit (DermNet); inconsistent study results (JAMA Dermatology summary) |
| Ketoconazole shampoo | Some evidence of benefit in men (DermNet) |
| Hair-loss shampoos | Can make hair look thicker but cannot regrow hair (AAD) |
Side effects and who should be careful
Minoxidil
The AAD lists scalp irritation, itchiness and headaches as possible side effects in men, and scalp irritation and unwanted facial hair in women. It notes that women may see a temporary increase in shedding for two to eight weeks after starting. Women should avoid minoxidil during pregnancy and breastfeeding, according to the AAD.
Finasteride
The AAD lists reduced sex drive, erectile problems, breast swelling or tenderness, and depression as possible side effects, and notes that sexual side effects may continue after stopping. A dermatologist reviews health history and current medicines before prescribing it.
Hormone-blocking pills in women
The AAD warns that prescription pills used off-label for female pattern hair loss can cause birth defects. They are not for women who are pregnant or planning pregnancy, and premenopausal women should use birth control while taking them.
Hair loss that looks different
Other conditions can look like pattern hair loss and need different treatment. The AAD recommends seeing a dermatologist to confirm the cause. For women, DermNet notes that the workup may include blood tests for sex hormones and thyroid function, and sometimes a scalp biopsy.
How to approach treatment
Start early
The AAD notes that treatment tends to work better when started soon after hair loss is noticed, and recommends seeing a dermatologist at the first sign.
Use it consistently
Topical minoxidil for men is applied to the scalp twice a day, every day, according to the AAD. Finasteride is taken as a daily pill over the long term.
Give it time
| Treatment | Time to judge results (AAD) |
|---|---|
| Topical minoxidil | 6 to 12 months |
| Finasteride (men) | About 6 months |
| Prescription pills for women | 6 to 12 months |
DermNet similarly notes that benefits take at least six months to assess.
Expect maintenance
The benefits last only as long as treatment continues. The AAD notes that stopping minoxidil leads to lost benefits and increased shedding, and that hair loss returns after stopping finasteride. DermNet advises not stopping treatment without talking to a doctor.
Set realistic goals
The AAD notes that full regrowth with minoxidil is unlikely, and that some people respond poorly or not at all. A dermatologist can explain which results are realistic for your type and stage of hair loss.
The short version
Androgenetic alopecia is inherited thinning in which follicles shrink over successive hair cycles and produce finer hairs. In men, follicle sensitivity to DHT drives the process; in women, the hormonal role is less clear and the pattern usually starts with a widening part. Minoxidil helps both sexes, and finasteride helps many men, but both take six to twelve months and need to be continued. A board-certified dermatologist can confirm the diagnosis and weigh the side effects for you.



